Search research articles
Contact Us
Filters
Showing results (111-120 of 466) with videos related to
Page
of 47
Sort By:
Infectious Agents and Cancer
|
February 25, 2021
Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
Dominic Kaddu-Mulindwa, Lorenz Thurner, Moritz Bewarder, et al.
Hemasphere
|
October 30, 2025
Overall survival outcomes with first-line continuous ibrutinib and fixed-duration ibrutinib-venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age-matched European population
Paolo Ghia, Loic Ysebaert, Ann Janssens, et al.
Cancer Research
|
November 19, 2009
A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia
Sandra Loeder, Thorsten Zenz, Andrea Schnaiter, et al.
Leukemia & Lymphoma
|
September 18, 2015
Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group
Valentin Goede, Jasmin Bahlo, Viktoria Chataline, et al.
Blood
|
March 26, 2010
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia
Maike Buchner, Constance Baer, Gabriele Prinz, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 30, 2010
Chronic lymphocytic leukemia: new concepts for future therapy
William G Wierda, Nicholas Chiorazzi, Claire Dearden, et al.
European Journal of Haematology
|
July 14, 2011
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia
Kai Uwe Chow, Soo-Zin Kim, Nils von Neuhoff, et al.
Leukemia & Lymphoma
|
April 7, 2009
Chronic lymphocytic leukemia and 13q14: miRs and more
Daniel Mertens, Angela Philippen, Melanie Ruppel, et al.
Leukemia & Lymphoma
|
April 7, 2009
Treatment resistance in chronic lymphocytic leukemia: the role of the p53 pathway
Thorsten Zenz, Julia Mohr, Jennifer Edelmann, et al.
Haematologica
|
August 2, 2007
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival
Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, et al.
Page
of 47
Search research articles
Search
Showing results (111-120 of 466) with videos related to
Sort By:
Page
of 47
Infectious Agents and Cancer
|
February 25, 2021
Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
Dominic Kaddu-Mulindwa, Lorenz Thurner, Moritz Bewarder, et al.
Hemasphere
|
October 30, 2025
Overall survival outcomes with first-line continuous ibrutinib and fixed-duration ibrutinib-venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age-matched European population
Paolo Ghia, Loic Ysebaert, Ann Janssens, et al.
Cancer Research
|
November 19, 2009
A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia
Sandra Loeder, Thorsten Zenz, Andrea Schnaiter, et al.
Leukemia & Lymphoma
|
September 18, 2015
Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group
Valentin Goede, Jasmin Bahlo, Viktoria Chataline, et al.
Blood
|
March 26, 2010
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia
Maike Buchner, Constance Baer, Gabriele Prinz, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 30, 2010
Chronic lymphocytic leukemia: new concepts for future therapy
William G Wierda, Nicholas Chiorazzi, Claire Dearden, et al.
European Journal of Haematology
|
July 14, 2011
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia
Kai Uwe Chow, Soo-Zin Kim, Nils von Neuhoff, et al.
Leukemia & Lymphoma
|
April 7, 2009
Chronic lymphocytic leukemia and 13q14: miRs and more
Daniel Mertens, Angela Philippen, Melanie Ruppel, et al.
Leukemia & Lymphoma
|
April 7, 2009
Treatment resistance in chronic lymphocytic leukemia: the role of the p53 pathway
Thorsten Zenz, Julia Mohr, Jennifer Edelmann, et al.
Haematologica
|
August 2, 2007
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival
Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, et al.
Page
of 47